Profound Medical Corp. (NASDAQ: PROF) reported Q4 EPS of $0.20, $0.55 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.18 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.